HeartMate II

Device Abbott Laboratories
Total Payments
$284,521
Transactions
197
Doctors
0
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2020 $165,375 79 0
2019 $94,839 92 0
2018 $24,308 26 0

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $284,521 197 100.0%

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
INvesTigation to OptimizE Hemodynamic Management of HeartMate II Left VentricuLar Assist DEvice Patients using the CardioMEMS Pulmonary ArTery Pressure Sensor in Advanced Heart Failure (INTELLECT 2-HF) Abbott Laboratories $157,223 0
PREVENTion of Non-Surgical Bleeding by Management of HeartMate II Patients without Antiplatelet Therapy Abbott Laboratories $95,383 0
Driveline Silicone Skin Interface Registry (SSI) Abbott Laboratories $29,213 0
Remission From Stage D Heart Failure (RESTAGE-HF) Abbott Laboratories $2,702 0

Top Doctors Receiving Payments for HeartMate II

Doctor Specialty Location Total Records
Unknown Atlanta, GA $284,521 197

About HeartMate II

HeartMate II is a device associated with $284,521 in payments to 0 healthcare providers, recorded across 197 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.

Payment data is available from 2018 to 2020. In 2020, $165,375 was paid across 79 transactions to 0 doctors.

The most common payment nature for HeartMate II is "Unspecified" ($284,521, 100.0% of total).

HeartMate II is associated with 4 research studies, including "INvesTigation to OptimizE Hemodynamic Management of HeartMate II Left VentricuLar Assist DEvice Patients using the CardioMEMS Pulmonary ArTery Pressure Sensor in Advanced Heart Failure (INTELLECT 2-HF)" ($157,223).